The US FDA has granted standard approval to the Alzheimer’s drug Leqembi, developed by EisaiBiogen.
In a groundbreaking development, the US Food and Drug Administration (FDA) granted standard approval to the Alzheimer’s drug Leqembi, jointly developed by Eisai and Biogen.